Latest news from Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) on News en-us Copyright 2024 News 115 31 / /images/newswise-logo-rss.gif /articles/americas-committee-for-treatment-and-research-in-multiple-sclerosis-actrims-outlines-guidance-for-diagnosing-pediatric-and-late-onset-multiple-sclerosis/?sc=rsin /articles/americas-committee-for-treatment-and-research-in-multiple-sclerosis-actrims-outlines-guidance-for-diagnosing-pediatric-and-late-onset-multiple-sclerosis/?sc=rsin Thu, 26 Sep 2024 15:05:53 EST A new review led by the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) provides guidance on how to diagnose suspected multiple sclerosis (MS) in individuals under 18 and adults 50 years and older. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/making-connections-will-be-the-focus-at-the-actrims-forum-2025/?sc=rsin /articles/making-connections-will-be-the-focus-at-the-actrims-forum-2025/?sc=rsin Thu, 01 Aug 2024 12:05:59 EST The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) is excited to announce its tenth annual Forum, taking place from February 27 to March 1, 2025, at the Palm Beach County Convention Center and the Hilton West Palm Beach in Florida. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/national-ms-society-awards-dr-sergio-baranzini-the-barancik-prize-for-innovation-in-ms-research/?sc=rsin /articles/national-ms-society-awards-dr-sergio-baranzini-the-barancik-prize-for-innovation-in-ms-research/?sc=rsin Tue, 30 Jan 2024 11:05:48 EST Sergio E. Baranzini, PhD, a geneticist, neuroimmunologist, and data scientist at the University of California, San Francisco, is the winner of this year's Barancik Prize for Innovation in MS Research. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/the-ninth-annual-actrims-forum-will-be-held-feb-29-march-2-in-west-palm-beach-florida/?sc=rsin /articles/the-ninth-annual-actrims-forum-will-be-held-feb-29-march-2-in-west-palm-beach-florida/?sc=rsin Thu, 03 Aug 2023 11:30:05 EST Breaking Barriers in MS will be the focus at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/is-it-ms-or-something-else-updated-guide-is-published-to-expedite-and-uncover-the-answer/?sc=rsin /articles/is-it-ms-or-something-else-updated-guide-is-published-to-expedite-and-uncover-the-answer/?sc=rsin Wed, 19 Jul 2023 18:30:00 EST An international consortium led by ACTRIMS has published detailed updated recommendations for how to distinguish suspected multiple sclerosis from other look-alike disorders. This critical guidance aims to reduce the time spent to confirm an accurate diagnosis of MS. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/actrims-forum-2023-themed-ms-going-viral/?sc=rsin /articles/actrims-forum-2023-themed-ms-going-viral/?sc=rsin Thu, 08 Sep 2022 13:05:32 EST The Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) annual Forum will be held Feb. 23-25, 2023, in San Diego, California at the Marriott Marquis San Diego Marina. Themed "MS: Going Viral," the Forum 2023, will address the role of different viruses that have been implicated in the ongoing disease process in MS, in particular the Epstein-Barr virus, which has been associated with the onset of MS. The Forum also features the Kenneth P. Johnson Memorial Lecture, which will be delivered by Dr. Lawrence Steinman. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/actrims-board-member-dr-amit-bar-or-wins-barancik-prize-for-innovation-in-ms-research/?sc=rsin /articles/actrims-board-member-dr-amit-bar-or-wins-barancik-prize-for-innovation-in-ms-research/?sc=rsin Thu, 17 Feb 2022 16:05:59 EST The National MS Society announced that Amit Bar-Or, MD, the Melissa and Paul Anderson President's Distinguished Professor of Neurology at the Perelman School of Medicine at the University of Pennsylvania is this year's recipient of the Barancik Prize for Innovation in MS Research. He is being honored for work uncovering how the immune system drives MS and for cutting-edge research focusing on precision medicine to achieve long-term remission and ultimately preventing progression of the disease. Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/evolution-of-the-neuroinflammatory-response-over-the-clinical-course-of-ms/?sc=rsin /articles/evolution-of-the-neuroinflammatory-response-over-the-clinical-course-of-ms/?sc=rsin Mon, 22 Feb 2021 13:05:42 EST Benjamin M. Segal, M.D., The Ohio State University, to present keynote address at ACTRIMS Forum 2021 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/the-spectrum-of-multiple-sclerosis-will-be-the-focus-at-americas-committee-for-treatment-and-research-in-multiple-sclerosis-actrims-2021-forum/?sc=rsin /articles/the-spectrum-of-multiple-sclerosis-will-be-the-focus-at-americas-committee-for-treatment-and-research-in-multiple-sclerosis-actrims-2021-forum/?sc=rsin Tue, 19 Jan 2021 11:40:16 EST Forum Announcement Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/actrims-ms-virtual-2020-qa-with-association-leadership/?sc=rsin /articles/actrims-ms-virtual-2020-qa-with-association-leadership/?sc=rsin Sat, 26 Sep 2020 17:10:00 EST ACTRIMS MS Virtual 2020 Q&A with Association Leadership Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/brain-microstructural-and-metabolic-alterations-detected-in-vivo-at-the-onset-of-the-first-demyelinating-event/?sc=rsin /articles/brain-microstructural-and-metabolic-alterations-detected-in-vivo-at-the-onset-of-the-first-demyelinating-event/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/primary-astrocytopathy-has-a-detrimental-effect-on-remyelination-efficacy-of-parenchymal-oligodendrocyte-precursor-cells/?sc=rsin /articles/primary-astrocytopathy-has-a-detrimental-effect-on-remyelination-efficacy-of-parenchymal-oligodendrocyte-precursor-cells/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/phase-2-clinical-trial-evidence-that-a-retinoid-x-receptor-agonist-promotes-remyelination-in-people-with-relapsing-remitting-multiple-sclerosis/?sc=rsin /articles/phase-2-clinical-trial-evidence-that-a-retinoid-x-receptor-agonist-promotes-remyelination-in-people-with-relapsing-remitting-multiple-sclerosis/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/neutrophil-granulocyte-markers-in-cerebrospinal-fluid-differentiate-nmosd-and-anti-mog-antibody-associated-disease-from-ms-in-acute-disease-phase/?sc=rsin /articles/neutrophil-granulocyte-markers-in-cerebrospinal-fluid-differentiate-nmosd-and-anti-mog-antibody-associated-disease-from-ms-in-acute-disease-phase/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/network-analysis-identifies-gut-bacteria-associated-with-multiple-sclerosis-relapse-among-pediatric-onset-patients/?sc=rsin /articles/network-analysis-identifies-gut-bacteria-associated-with-multiple-sclerosis-relapse-among-pediatric-onset-patients/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/interrupting-disease-modifying-treatment-for-pregnancy-in-multiple-sclerosis-effect-on-disease-activity-and-serum-neurofilament-light-chain/?sc=rsin /articles/interrupting-disease-modifying-treatment-for-pregnancy-in-multiple-sclerosis-effect-on-disease-activity-and-serum-neurofilament-light-chain/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/covid-19-in-persons-with-multiple-sclerosis-treated-with-ocrelizumab-pharmacovigilance-update/?sc=rsin /articles/covid-19-in-persons-with-multiple-sclerosis-treated-with-ocrelizumab-pharmacovigilance-update/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/first-results-of-the-covid-19-in-ms-global-data-sharing-initiative-suggest-anti-cd20-dmts-are-associated-with-worse-covid-19-outcomes/?sc=rsin /articles/first-results-of-the-covid-19-in-ms-global-data-sharing-initiative-suggest-anti-cd20-dmts-are-associated-with-worse-covid-19-outcomes/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/comparison-of-covid-19-outcomes-between-racial-groups-in-the-covims-registry/?sc=rsin /articles/comparison-of-covid-19-outcomes-between-racial-groups-in-the-covims-registry/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) /articles/clinical-characteristics-and-outcomes-in-patients-with-coronavirus-disease-2019-and-multiple-sclerosis/?sc=rsin /articles/clinical-characteristics-and-outcomes-in-patients-with-coronavirus-disease-2019-and-multiple-sclerosis/?sc=rsin Fri, 25 Sep 2020 07:00:00 EST Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS)